[The so-called toxicity of hyperbaric oxygen as an adrenergic phenomenon. Proposals for a pathogenetic interpretation].
D000251:Adenosine Triphosphatases / Q000032:analysis; D000313:Adrenal Medulla / Q000502:physiology; D000469:Alkaline Phosphatase / Q000032:analysis; D000818:Animals; D001544:Benperidol / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D006651:Histocytochemistry; D006931:Hyperbaric Oxygenation / Q000009:adverse effects*; D008049:Lipase / Q000032:analysis; D008168:Lung / Q000201:enzymology / Q000473:pathology*; D008297:Male; D009708:Nucleotidases / Q000032:analysis; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012640:Seizures / Q000209:etiology*; D013564:Sympathetic Nervous System / Q000502:physiology*; D013565:Sympatholytics
D013565:Sympatholytics; D012110:Reserpine; D001544:Benperidol; D008049:Lipase; D009708:Nucleotidases; D000469:Alkaline Phosphatase; D000251:Adenosine Triphosphatases; D002746:Chlorpromazine
La cosiddetta tossicità dell'ossigeno iperbarico come fenomeno adrenergico. Proposta di interpretazione patogenetica.